A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer
| Autor: | Heinemann, V. *, Di Gioia, D., Vehling-Kaiser, U., Harich, H.-D., Heinrich, B., Welt, A., Ziske, C., Deutsch, G., Pihusch, R., Kölbl, H., Hegewisch-Becker, S., Michl, M., Stemmler, H.J. |
|---|---|
| Zdroj: | In Annals of Oncology March 2011 22(3):603-608 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|